Clinical Pharmacy

CP-048

ANALYSIS OF THE AMBULATORY USE OF BOTULINUM TOXIN TYPE A IN A TERTIARY HOSPITAL: AUTHORIZED AND OFF-LABEL INDICATIONS

CP-047

PHARMACIST'S CONTRIBUTION TO THE OPTIMIZATION OF DRUG THERAPY IN ONCOLOGY INPATIENTS

CP-046

HYPERSENSITIVITY REACTIONS TO CHEMOTHERAPY: SO... WHAT DO WE DO NOW?

CP-045

ELECTRONIC PRESCRIBING: THE DEVELOPMENT OF A PAEDIATRIC DRUG DATABASE

CP-044

EFFECTIVENESS AND SAFETY OF IMATINIB IN CHRONIC MYELOID LEUKEMIA IN A TERTIARY HOSPITAL

CP-043

IMPLEMENTATION OF EXTENDED TOP-UP SERVICE INCREASED CORRECT RECORDING IN THE ELECTRONIC MEDICATION MODULE

CP-040

SWITCHING TO TENOFOVIR/ EMTRICITABINE/RILPIVIRINE IN HIV-1 PATIENTS PREVIOUSLY TREATED WITH TENOFOVIR/EMTRICITABINE/EFAVIRENZ

CP-038

ADEQUACY OF NUTRITION ENERGY DELIVERY IN SURGICAL INTENSIVE CARE

CP-037

EFICACY OF ABIRATERONE IN THE TREATMENT OF PROSTATE CANCER

CP-036

DRUG INTERACTIONS INVOLVING ANTIBIOTICS: DO THEY CARE?

CP-034

IPILIMUMAB EXPERIENCE IN ADVANCED MELANOMA

CP-033

USE OF INFLIXIMAB IN A PREGNANT WOMAN WITH ANKYLOSING SPONDYLITIS

CP-032

OFF-LABEL USE OF ADALIMUMAB IN BEHÇET'S DISEASE. A CASE REPORT

CP-027

EFFICACY AND SAFETY OF RIBAVIRIN USED FOR RESPIRATORY SYNCITIAL VIRUS TREATMENT IN HEMATOLOGICAL PATIENTS

CP-026

EFFICACY OF TRIPLE THERAPY WITH PROTEASE INHIBITORS FOR THE TREATMENTOF HEPATITIS C VIRUS IN CLINICAL PRACTICE

Pages